Barrett's Esophagus Journal Articles

• Management of NAFLD in Primary Care Settings This review offers practical tips on diagnosis and management of NAFLD in primary care, highlighting the importance of building a clinical care pathway linking primary and specialist care.
  Liver International, October 26, 2022
• Role of Ambulatory Reflux Monitoring in PPI Non-responders An expert panel provides recommendation statements regarding the clinical utilization and interpretation of ambulatory reflux monitoring in patients who have not responded to PPIs.
  Alimentary Pharmacology & Therapeutics, October 24, 2022
• Medical Malpractice and Gastrointestinal Endoscopy This paper explores malpractice as it relates to gastroenterologists, including historical trends and specific vulnerabilities. How can the gastroenterologist best manage risk while delivering care?
  Current Opinion in Gastroenterology, August 22, 2022
• Non-esophageal Eosinophilic GI Diseases Are Underdiagnosed Are non-esophageal gastrointestinal eosinophilic diseases as rare as commonly thought, or does low awareness of EGIDs contribute to underdiagnosis?
  Alimentary Pharmacology & Therapeutics, August 01, 2022
• H. Pylori Infection, GERD, and Its Complications This review aimed to elucidate the association between H. pylori infection and GERD symptoms, erosive esophagitis, and Barrett's esophagus. Might H. pylori infection provide a protective effect?
  Alimentary Pharmacology & Therapeutics, November 03, 2021
• Family History and Risk of Barrett's Esophagus How much impact does family history have on the risk of developing Barrett's esophagus or esophageal adenocarcinoma?
  Alimentary Pharmacology & Therapeutics, October 18, 2021
• Duodenogastroesophageal Reflux Prevalence and Treatment How prevalent is duodenogastroesophageal, or "bile", reflux, and what is its impact on GERD symptoms and esophageal lesions?
  Alimentary Pharmacology & Therapeutics, October 04, 2021
• Chronic Use of Ranitidine and Gastrointestinal Malignancies Unacceptable levels of NDMA in ranitidine caused it to be removed it from the market. Do patients who took ranitidine have a higher risk of GI cancer compared with those on other anti-reflux drugs?
  Alimentary Pharmacology & Therapeutics, September 08, 2021
• Tegoprazan vs. Placebo in Non-erosive Reflux Disease Is tegoprazan, a novel, long-acting potassium-competitive acid blocker, superior to placebo in patients with non-erosive reflux disease?
  Alimentary Pharmacology & Therapeutics, August 30, 2021
• Cancer Screening in Idiopathic Inflammatory Myopathies What are the cancer risk factors in patients with idiopathic inflammatory myopathies, and how often should they be considered for screening?
  Rheumatology, July 09, 2021
• Medication Use and Microscopic Colitis This study examined the association between microscopic colitis and several classes of medications, including NSAIDs, PPIs, H2 blockers, and oral diabetes medications.
  Alimentary Pharmacology & Therapeutics, July 07, 2021
• The UCLA GIT 2.0 as a Decision Aid in Systemic Sclerosis Learn more about the potential role the UCLA GIT 2.0 could have in the management of systemic sclerosis.
  Arthritis Research & Therapy, June 10, 2021
• Risk Factors for Barrett's Esophagus in Individuals With GERD Which potential risk factors might contribute to the development of Barrett's esophagus in individuals with gastro-esophageal reflux symptoms?
  Alimentary Pharmacology & Therapeutics, May 19, 2021
• Esophageal Cancer: An Updated Review The incidence of esophageal cancer is on the rise. Review its epidemiology, risk factors, diagnosis and management in this update.
  Southern Medical Journal, April 05, 2021
• Banded Versus Nonbanded Sleeve Gastrectomy How do these two techniques for sleeve gastrectomy compare in terms of weight loss and complications?
  Annals of Surgery, November 03, 2020
• Esophageal Radiofrequency for PPI-Refractory Heartburn Is esophageal radiofrequency an effective alternative to PPI treatment among patients with refractory heartburn?
  Alimentary Pharmacology & Therapeutics, August 31, 2020
• The Effects of PPIs on the Microbiome of the Digestive Tract Using evidence from next-generation sequencing studies, this review examined the association of PPIs with alterations to gut microbiota. What are the implications of PPI-induced dysbiosis?
  Alimentary Pharmacology & Therapeutics, March 30, 2020
• Appropriate Use and Stewardship of Proton-Pump Inhibitors While proton-pump inhibitors are effective for a wide variety of conditions, they are not without risk, especially when used long-term. Review their appropriate and inappropriate use in this article.
  U.S. Pharmacist, January 31, 2020
• Reported PPI Side Effects: Physician and Patient Perspectives Are users of proton pump inhibitors changing their behavior based upon concerns regarding side effects? Are physicians changing their management strategies?
  Alimentary Pharmacology & Therapeutics, January 20, 2020
• PPIs: Placing Putative Adverse Effects in Proper Perspective Are doctors modifying PPI therapy based on solid scientific evidence? Most serious adverse effects attributed to PPIs are based on observational data.
  Current Opinion in Gastroenterology, October 30, 2019